A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI)
BMJ open, Volume 4, Issue 2, 2014, Pages e004258-e004258.
research methodsbiomedical researchbioinformatics
Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide despite the latest therapeutic advances designed to decrease myocardial injury. Preclinical and emerging clinical evidence show that the intracoronary injection of autologous bone marrow mononuclear cells (BMCs) following AMI leads to improvement ...More
Full Text (Upload PDF)
PPT (Upload PPT)